NYSE - Delayed Quote USD
Novartis AG (NVS)
110.13
-1.28
(-1.15%)
At close: April 23 at 4:00:02 PM EDT
110.62
+0.49
+(0.44%)
Pre-Market: 5:10:08 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
17,619,000
17,619,000
14,458,000
14,236,000
15,071,000
Investing Cash Flow
-7,513,000
-7,513,000
5,596,000
1,468,000
4,208,000
Financing Cash Flow
-11,742,000
-11,742,000
-14,278,000
-20,562,000
-16,264,000
End Cash Position
11,459,000
11,459,000
13,393,000
7,517,000
12,407,000
Capital Expenditure
-3,814,000
-3,814,000
-2,753,000
-2,239,000
-2,556,000
Issuance of Debt
7,101,000
7,101,000
546,000
252,000
16,000
Repayment of Debt
-2,711,000
-2,711,000
-2,481,000
-2,837,000
-5,987,000
Repurchase of Capital Stock
-8,331,000
-8,331,000
-8,719,000
-10,652,000
-3,057,000
Free Cash Flow
13,805,000
13,805,000
11,705,000
11,997,000
12,515,000
12/31/2021 - 11/7/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNY Sanofi
53.02
+2.26%
AZN AstraZeneca PLC
68.51
+0.94%
GSK GSK plc
37.03
+1.09%
RHHBY Roche Holding AG
39.14
+0.08%
AMGN Amgen Inc.
277.90
-0.18%
ROG.SW Roche Holding AG
257.70
-0.15%
GILD Gilead Sciences, Inc.
106.38
+0.82%
MRK Merck & Co., Inc.
78.74
-0.29%
BIIB Biogen Inc.
118.17
-0.61%
BMY Bristol-Myers Squibb Company
48.53
-2.59%